BD PharmingenTM PE Mouse Anti-Human IL-17RA (CD217)

Description

Flow cytometric analysis of IL-17RA CD217 expression on peripheral blood leucocytes. Whole blood was stained with either PE Mouse IgG1, kappa Isotype Control Cat. No. 554680; Left Plot or PE Mouse Anti-Human CD217 IL-17RA Cat. No. 566736; Right Plot at 0.5 mug/test. Samples were then treated with 1 BD Pharm Lyse lysing solution Cat. No. 555899 to remove erythrocytes. The contour plots showing IL-17RA CD217 or Ig isotype control staining versus side light-scatter were derived from gated events with the forward and side light-scatter characteristics of viable leucocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa Cell Analyzer System and FlowJo software. Data shown on this Technical Data Sheet are not lot specific. Flow cytometric analysis of IL-17RA CD217 expression on peripheral blood leucocytes. Whole blood was stained with either PE Mouse IgG1, kappa Isotype Control Cat. No. 554680; Left Plot or PE Mouse Anti-Human CD217 IL-17RA Cat. No. 566736; Right Plot at 0.5 mug/test. Samples were then treated with 1 BD Pharm Lyse lysing solution Cat. No. 555899 to remove erythrocytes. The contour plots showing IL-17RA CD217 or Ig isotype control staining versus side light-scatter were derived from gated events with the forward and side light-scatter characteristics of viable leucocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa Cell Analyzer System and FlowJo software. Data shown on this Technical Data Sheet are not lot specific. Flow cytometric analysis of IL-17RA CD217 expression on peripheral blood leucocytes. Whole blood was stained with either PE Mouse IgG1, kappa Isotype Control Cat. No. 554680; Left Plot or PE Mouse Anti-Human CD217 IL-17RA Cat. No. 566736; Right Plot at 0.5 mug/test. Samples were then treated with 1 BD Pharm Lyse lysing solution Cat. No. 555899 to remove erythrocytes. The contour plots showing IL-17RA CD217 or Ig isotype control staining versus side light-scatter were derived from gated events with the forward and side light-scatter characteristics of viable leucocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa Cell Analyzer System and FlowJo software. Data shown on this Technical Data Sheet are not lot specific. Show More Flow cytometric analysis of IL-17RA CD217 expression on peripheral blood leucocytes. Whole blood was stained with either PE Mouse IgG1, kappa Isotype Control Cat. No. 554680; Left Plot or PE Mouse Anti-Human CD217 IL-17RA Cat. No. 566736; Right Plot at 0.5 mug/test. Samples were then treated with 1 BD Pharm Lyse lysing solution Cat. No. 555899 to remove erythrocytes. The contour plots showing IL-17RA CD217 or Ig isotype control staining versus side light-scatter were derived from gated events with the forward and side light-scatter characteristics of viable leucocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa Cell Analyzer System and FlowJo software. Data shown on this Technical Data Sheet are not lot specific. Show More Flow cytometric analysis of IL-17RA CD217 expression on peripheral blood leucocytes. Whole blood was stained with either PE Mouse IgG1, kappa Isotype Control Cat. No. 554680; Left Plot or PE Mouse Anti-Human CD217 IL-17RA Cat. No. 566736; Right Plot at 0.5 mug/test. Samples were then treated with 1 BD Pharm Lyse lysing solution Cat. No. 555899 to remove erythrocytes. The contour plots showing IL-17RA CD217 or Ig isotype control staining versus side light-scatter were derived from gated events with the forward and side light-scatter characteristics of viable leucocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa Cell Analyzer System and FlowJo software. Data shown on this Technical Data Sheet are not lot specific. Flow cytometric analysis of IL-17RA CD217 expression on peripheral blood leucocytes. Whole blood was stained with either PE Mouse IgG1, kappa Isotype Control Cat. No. 554680; Left Plot or PE Mouse Anti-Human CD217 IL-17RA Cat. No. 566736; Right Plot at 0.5 mug/test. Samples were then treated with 1 BD Pharm Lyse lysing solution Cat. No. 555899 to remove erythrocytes. The contour plots showing IL-17RA CD217 or Ig isotype control staining versus side light-scatter were derived from gated events with the forward and side light-scatter characteristics of viable leucocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa Cell Analyzer System and FlowJo software. Data shown on this Technical Data Sheet are not lot specific.